1. Home
  2. BOF vs SCLX Comparison

BOF vs SCLX Comparison

Compare BOF & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BranchOut Food Inc.

BOF

BranchOut Food Inc.

HOLD

Current Price

$3.97

Market Cap

63.6M

ML Signal

HOLD

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$5.75

Market Cap

55.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOF
SCLX
Founded
2017
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.6M
55.1M
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
BOF
SCLX
Price
$3.97
$5.75
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
21.3K
54.6K
Earning Date
05-14-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
31.33
N/A
EPS
N/A
N/A
Revenue
$3,184,018.00
$30,253,000.00
Revenue This Year
N/A
$122.52
Revenue Next Year
N/A
$186.30
P/E Ratio
N/A
N/A
Revenue Growth
258.20
N/A
52 Week Low
$1.93
$4.20
52 Week High
$5.25
$34.27

Technical Indicators

Market Signals
Indicator
BOF
SCLX
Relative Strength Index (RSI) 42.52 33.56
Support Level $3.82 $5.48
Resistance Level $3.96 $7.77
Average True Range (ATR) 0.20 0.40
MACD -0.04 -0.08
Stochastic Oscillator 3.89 12.68

Price Performance

Historical Comparison
BOF
SCLX

About BOF BranchOut Food Inc.

Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients. The products are mainly sold through three channels: branded retail snack products, private label products for retailers, and fruit and vegetable ingredients sold to food manufacturers.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

Share on Social Networks: